|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.28 USD | -0.97% |
|
-3.34% | +1.86% |
| 02:24pm | Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case | DJ |
| 01:31pm | Halozyme wins preliminary injunction against Merck's Keytruda SC in Germany | RE |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

































